| Date | Title | Description | Source |
| 08.05.2023 | How to Ensure Quality and Reliability for At-Home Lab Tests | A robust business model prioritizing quality at every step of the process is central to any successf... | medcitynew... |
| 17.04.2023 | Complement Therapeutics closes $79M A round for gene therapy... | Complement Therapeutics closes $79M A round for gene therapy in geographic atrophy
BioWorld | By Co... | cic.vc/new... |
| 10.01.2023 | Clarivate Identifies Fifteen Potential Blockbuster Drugs in ... | Report highlights personalized medicines ensuring greater efficacy for rare diseases and previously ... | en.prnasia... |
| 12.12.2022 | Digital health news, funding round up in the prior week; Dec... | Apogee Therapeutics raised $149M; Palantir renewed its partnered with the CDC; Ubie raised $19M
Top... | vator.tv/n... |
| 25.04.2022 | Cambridge Innovations raises £225M fund amid high interest i... | Cambridge Innovations raises £225M fund amid high interest in university spinouts
BioWorld article ... | cic.vc/new... |
| 15.03.2022 | Egg Medical hatches $13M VC funding |
March 4, 2022
By Annette Boyle
Egg Medical Inc. secured a $13 million investment from TVM Capita... | tvm-lifesc... |
| 09.03.2022 | Sense Biodetection sets sights on Europe after CE mark appro... | Sense Biodetection sets sights on Europe after CE mark approval
BioWorld article | By Catherine Lon... | cic.vc/new... |
| 07.02.2022 | Clarivate Identifies Seven Medtech Trends to Watch in 2022 | Ongoing recovery from COVID-19 causing renewed pressures on procedure volumes and less urgent interv... | marketscre... |
| 23.08.2021 | Could HIV be cured by tackling ‘bumpy’ CD4 cells? France’s D... | Finding a functional cure to HIV is one of the biggest challenges in modern medicine, a task made so... | truffle.co... |
| 10.02.2021 | Discover the Medical Isotope & Radiopharmaceutical Lands... | Did you know that Canada has been a global leader in the research, development and production of med... | admarebio.... |
| 12.01.2021 | QAD : Manufacturers Adapt to Protect Frontline Workers Again... | Whew…2020 is behind us. That means it allgets easier now, right?
Not exactly. But in truth, it wasn... | marketscre... |
| 20.12.2020 | Bringing Routine Covid-19 Testing Into The Home | Detect rapid molecular isothermal systemDetect
Great news that vaccines are getting approved. Atten... | forbes.com... |
| 21.09.2020 | Evolution Of The Biotech IPO Markets From Busted To Booming | getty
In the excitement of today’s biotech IPO market, and the bullish period since 2013, it’s almo... | forbes.com... |
| 08.09.2020 | Celltrion to begin mass producing antibody treatment... | In the race for something — anything — to rein in the pandemic, Celltrion says it will begin ... | endpts.com... |
| 23.06.2020 | Corporate innovation weekly: the rise of hydrogen | Automotive Battery breakthroughs
Volkswagen invested a further $200m into QuantumScape, a US startu... | sifted.eu/... |
| 07.04.2020 | Corporate innovation weekly: kidney research on hold, home d... | Computing Face-off
Microsoft’s M12 investment arm is divesting its stake in Israeli facial recognit... | sifted.eu/... |
| 11.03.2020 | AI is a 'potent weapon’ for fighting COVID-19 | COVID-19 might be incurable as yet, but humans have some potent weapons in our own arsenal, includin... | itweb.co.z... |
| 05.03.2020 | Consolidation in fintech: why it's happening and what it mea... | With Visa buying Plaid and Intuit buying Credit Karma, fintech M&A is on the rise
[Editor's not... | vator.tv/n... |
| 16.01.2020 | Daily funding roundup - January 16th, 2020 | Pawlicy Advisor raised $1M; Arpeggio Bio closed $3.2M; Gentem landed $3.7M; Loliware secured $5.9M
... | vator.tv/n... |
| 05.10.2018 | European biotech funding on track for record year | The European biotech sector is on track to break its annual funding record, according to BioWorld. A... | fiercebiot... |
| 05.10.2018 | European biotech funding on track for record year | The European biotech sector is on track to break its annual funding record, according to BioWorld. A... | fiercebiot... |
| 04.10.2018 | Natalie Sacks lands at Harpoon after jumping ship at Ad... | Natalie Sacks
→ We now know where Natalie Sacks was headed after jumping ship at Aduro $ADRO... | endpts.com... |
| 27.01.2017 | Ouch: Eli Lilly is walking away from Adocia deal and its ... | A little more than two years ago, Eli Lilly admitted it had made a big mistake in dumping Ado... | endpts.com... |
| 27.01.2017 | Everyone everywhere could only dream of a customer like this | By design, those quotes from customers are planned and canned.
So it was quite a departure from the... | medcitynew... |
| 22.12.2016 | Aurinia rallies $25M for lupus nephritis drug | Back in October, Aurinia’s stock surged 10 percent in a matter of minutes, based on speculation that... | medcitynew... |
| 11.08.2016 | Protocols: Infinity hunts up a buyer for its disappo... | AbbVie’s decision to abruptly pull out of its partnership with Infinity on duvelisib lar... | endpts.com... |
| 18.12.2015 | Pharmalot, Pharmalittle: Glaxo acquires HIV drugs, Gilead ge... | And so, another working week will soon draw to a close. Not a moment too soon, yes? After all, this ... | statnews.c... |
| 15.01.2015 | #JPM15 Day 3 Buzz: We’ve captured the mood at JP Morgan – an... | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficient... | medcitynew... |
| 09.09.2014 | “Deep sequencing” finds hidden causes of brain disorders | New methods can find mutations that strike just 1 in 10 cells in a sample.
By Nancy Fliesler
It’s ... | massdevice... |
| 04.11.2013 | Jim Blair’s Early Days with Amgen to New ‘Domain’ |
It’s hard to imagine there was a time when stalwart biotech giant Amgen Inc. was just a small star... | domainvc.c... |
| 10.10.2013 | San Diego Life Sciences Roundup: Tandem Diabetes, Ligand, an... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The IPO market for life sciences s... | xconomy.co... |
| 31.07.2013 | Why Deborah Dunsire’s Unusual Bet on Alzheimer’s Makes Sense... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Just because a biotech company has... | xconomy.co... |
| 10.04.2013 | RNAi therapeutics company starts up in San Diego with $580K | That’s a pretty big task, though. RNAi has been thought to harness potential in treating cancer and ... | medcitynew... |
| 11.01.2013 | Who are the top-earning R&D executives in biotech? | The top five earners, ranked by total compensation, in 2011 were:
George Yancopoulos, founding scien... | medcitynew... |
| 11.06.2009 | Sans IPO, Bayhill secures $350M in Genentech licensing deal | Months after giving up on its IPO hopes last year — when the market was especially brutal for lifesc... | venturebea... |
| 27.11.2007 | Cancer-drug biotech Agensys sells to Astellas for $387M — bu... | Yet another biotech has succumbed to Big Pharma’s deep-pocketed blandishments. Agensys, a decade-old... | venturebea... |
| 21.08.2007 | Life sciences briefing: Tuesday, Aug. 21, 2007 | (UPDATED at 7:40pm PT: See below.)
Featured companies: Adnexus Therapeutics, BioForm Medical, Confi... | venturebea... |
| 26.06.2007 | Ceregene: Catching an updraft in gene therapy | (UPDATED: See below.)
Ceregene, a San Diego biotech at work on a gene therapy for Parkinson’s disea... | venturebea... |
| - | Everyone everywhere could only dream of a customer like this | In the business world, customer testimonials are gold especially for young startups hoping to open d... | medcitynew... |
| - | RNAi therapeutics company starts up in San Diego with $580K | Since Craig C. Mello and Andrew Fire published a paper in Nature on the gene-silencing effect of RNA... | medcitynew... |
| - | The Meta AI mafia: Meet 12 artificial intelligence researche... | Anna Buldakova, Eric Steinberger, and Anna Susmeji Anna Buldakova/ClimateScience/Anna Susmeji This s... | businessin... |
| - | Aurinia rallies $25M for lupus nephritis drug | Move right along. There’s no acquisition here — for now.
Canadian biotech Aurinia Pharmaceuticals a... | medcitynew... |
| - | Who are the top-earning R&D executives in biotech? | As biotech R&D spending grows, and a steady stream of biotech products continues to win regulato... | medcitynew... |
| - | #JPM15 Day 3 Buzz: We’ve captured the mood at JP Morgan – an... | Someone said it: “We’re not limited by capital.”
FierceBiotech on Wednesday delivered the first big... | medcitynew... |
